Click to Share
 

Filter News
Show All Results
News By Country
News By Industry
Biotech Remove
News By Subject


January 2026
WeTuMoSuSaFrTh
141312111098

Public Company News

Business Press Releases

Biotech Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

Premium Press Releases | Show All

13121602
203 views, By CorporateAds
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP has Entered into a Joint Offering with neurocare Group for Neuroplastic Therapy Targeting Depression, PTSD and Other Mental Health Afflictions
13116861
510 views, By CorporateAds
VSee Health, Inc. (N A S D A Q: VSEE) $VSEE Reported Q3 Revenues Reach $3.98 Million, Up 19% Year-Over-Year with Clients Including NASA, U.S. Department of Health and Human Services, McKesson, DaVita and The Nation of Qatar
13114497
510 views, By CorporateAds
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) NRXP Also Reports Its Superior Preservative-Free IV Ketamine Now Submitted for FDA Abbreviated New Drug Application
787 views, By OKAVA
OKAVA Pharmaceuticals is a clinical-stage company developing medicines to enable dogs and cats to live longer, healthier lives.
13114257
725 views, By CorporateAds
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP; $750 Million Market for Suicidal Depression Market Awaits
1429 views, By The ROS1ders, Inc.
The ROS1ders, a global group of patients and caregivers living with ROS1+ cancer, announced the recipient of the 2025 ROS1+ Cancer Innovation Award.
13111468
783 views, By Corporate Ads
$NRXP Has Manufactured Multiple Commercial Lots of NRX-100 and KETAFREE™ with a Shelf Life of Three Years.
13110095
638 views, By Corporate Ads
Analyst D. Boral Targets NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP at $34 Per Share — Pioneering Breakthroughs in Treatment-Resistant Depression and Chronic Pain
13110041
696 views, By Corporate Ads
H.C. Wainwright Initiates Coverage with $34 Price Target, Citing Paradigm Shift in Depression Treatment. NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP
13109922
945 views, By 360Disruption FZE
Founder of 360Disruption leads cross-border FDI and healthtech ventures aligned with UAE Vision 2031 and GCC Vision frameworks.
13109195
1079 views, By WorldUpstart
After six intensive weeks of online programming, WorldUpstart welcomed its 10th international cohort of startups to Philadelphia for a high-impact, in-person Industry Showcase.
13107293
504 views, By Phinge Corporation
Following its recent announcement detailing its upcoming Netverse® platform's potential capabilities for securing clinical trials, Phinge® is highlighting how the same patented, hardware-verified technology can revolutionize research for cancer and...
13107079
681 views, By DERMA-CODE LLC
DERMA-CODE™ discloses its complete INCI lists and design approach for its upcoming NAD⁺ + PDRN + Peptide serum and moisturizer, emphasizing dermatologist testing, MoCRA compliance, and ingredient transparency.
13107045
1152 views, By Phinge Corporation
Phinge Corporation, the innovator behind the upcoming patented, app-less Netverse® platform, today announced that its technology is poised to revolutionize the clinical trial landscape.
13106071
527 views, By MDRN MUSE
MDRN MUSE announces its inclusion in Delta Dental PPO, Delta Dental Premier, and Cigna networks, broadening access to affordable, high-quality dental care in Chattanooga.
13105700
519 views, By New You Smile Dental Implant Center
New You Smile Dental Implant Center has expanded its office to suite 340a in the Mercy South Medical Building, enhancing dedicated patient care specific to full arch dental implant services for failing and edentulous patients in the St. Louis area.

All Press Releases

88 views, By SNS Research
SNS Intel is an Market Intelligence Platform for visual market intelligence across pharmaceutical and healthcare markets currently launching with Dermatology In Sight Module featuring in visual dashboards and Skin Cancer & Psoriasis as Focus areas
13121602
203 views, By CorporateAds
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP has Entered into a Joint Offering with neurocare Group for Neuroplastic Therapy Targeting Depression, PTSD and Other Mental Health Afflictions
162 views, By Best Nutrition Products Inc
Degenarative Cells required high value nutritional supplements for possible repairing and reconstruction. Dr. Abhay Kumar Pati, Natural Health Researcher, Author.
123 views, By o2h Discovery
o2h Discovery, a preclinical contract research organization (CRO) with a fully integrated, multi-modality drug discovery platform, is pleased to announce the launch of the latest edition of the o2h Kickstarter in "North America." This program is...
151 views, By Medpharma News
The Antibody Production Market is forecast to grow from USD 17.3 billion in 2022 to USD 59.1 billion by 2032 at a CAGR of 13.2%, driven by increased R&D, chronic disease prevalence, and advancements in antibody technologies.
610 views, By LactaLogics
LactaLogics, a company focused on human milk-based nutrition for premature and at-risk infants, recently announced its new processing facility in Port St. Lucie is near completion.
276 views, By Medpharma News
The Oligonucleotide Synthesis Market is projected to grow from USD 7.4 billion in 2022 to USD 25.3 billion by 2032 at a CAGR of 13.3%, fueled by expanding therapeutic, diagnostic, and research applications.
155 views, By Bundelkhand Bio Power Private Limited
Bundelkhand Bio Power Private Limited has initiated an integrated renewable energy pilot project in Bilanda village of Fatehpur district, focusing on biogas, Bio-CNG and circular waste management solutions for rural sustainability.
136 views, By Medpharma News
The Metagenomics Market is projected to grow from USD 1.4 billion in 2022 to USD 5.2 billion by 2032 at a 14.5% CAGR, fueled by clinical, environmental, and biotech applications.
136 views, By Medpharma News
The Beta-carotene Market is projected to grow from USD 455 million in 2022 to USD 723 million by 2032, driven by demand from supplements, food fortification, and cosmetics.
256 views, By Metavalis Inc.
The veteran led deep tech firm taps the renowned regulatory strategist and PharmaVoice 100 Honoree to architect the compliance framework for its re-dosable genetic medicines and solid state neural preservation systems.
290 views, By Metavalis Inc.
The veteran led deep tech firm defines a new standard for optical computing, initiating the development of a proprietary differentiable physics kernel to solve the Non Linear Schrödinger Equation.
213 views, By Newpage Solutions
Newpage has announced a major expansion of its global delivery footprint with the launch of a new Chennai Newton Center, the expansion of its Bangalore Einstein Center, and plans to open a new office in Bristol in 2026.
353 views, By Metavalis Inc.
Missouri Based Biotech Firm Reveals "Project AETHELGAARD"A Unified Physics Architecture capable of 1 Tbps Neural State Transfer and Geological Scale Data Preservation.
158 views, By Medpharma News
The Drug Discovery Market is projected to grow from USD 81.5 billion in 2022 to USD 181.4 billion by 2032 at a CAGR of 8.5%, driven by innovation and chronic disease research.
170 views, By Ameco Research
The Cancer Gene Therapy Market is forecast to reach USD 16.9 billion by 2032, growing at a 19.7% CAGR, driven by innovations in gene technologies and rising cancer treatment demand.
237 views, By Metavalis Inc.
Elite Advisory Board Comprising Veterans from Moderna, NIH, and U.S. Defense Assembled to Guide Secure LNP Development in the Ozarks.
284 views, By Metavalis Inc.
Data driven signal validates the company's "Failure Doctrine" operational model, positioning the Missouri based firm as a pre-seed outlier in the convergence of genomic medicine and optical computing.
13116861
510 views, By CorporateAds
VSee Health, Inc. (N A S D A Q: VSEE) $VSEE Reported Q3 Revenues Reach $3.98 Million, Up 19% Year-Over-Year with Clients Including NASA, U.S. Department of Health and Human Services, McKesson, DaVita and The Nation of Qatar
381 views, By Metavalis Inc.
Metavalis OS introduces a self modifying, dual AI command center featuring military grade security, a 9 tier rank system, HIPAA EHR, and a meta conscious Singularity Engine for autonomous biotech operations.
318 views, By Precision Antibody
Precision Antibody, a leading provider of custom monoclonal antibody development services, is pleased to announce its participation in Antibody Engineering & Therapeutics Event, on December 14–17, 2025, at the Marriott Marquis San Diego, California
409 views, By Metavalis
Bioengineering firm recruiting founding advisors in Lipid Physics, Hepatology, and Regulatory Affairs to guide its Smart LNP 3.0 platform and Dec 24th IP filing.
194 views, By Medpharma News
Monoclonal Antibodies Market valued at USD 195.6 Billion in 2022 is projected to reach USD 612.2 Billion by 2032, driven by chronic diseases and expanding biologics demand.
195 views, By Best Nutrition Products Inc
Black Turmeric and it's Therapeutic Properties Dr.Abhay Kumar Pati, BAMS, Phd, Dsc, An Ayurvedic Physician, Researcher Organic Fresh Black Turmeric is a premium food-grade ingredient celebrated for its unique black color and rich nutrients.
236 views, By Best Nutrition Products Inc
Nutmeg an Ayurvedic Spice Contains many good therapeutics Value Dr.Abhay Kumar Pati, BAMS, Phd, D.sc.
229 views, By HIREVets.gov
The U.S. Department of Labor has recognized Phronetik Inc. as one of the record-breaking 887 recipients of the 2025 HIRE Vets Medallion Award. Phronetik earned the platinum award after applying earlier this year.
398 views, By cdmoworld.com
Launch Party to Be Held This Thursday at the University of Massachusetts Club, Boston
225 views, By Ameco Research
The Gamma-Polyglutamic Acid Market is projected to grow from USD 442.3 Million in 2023 to USD 835.3 Million by 2032, driven by rising demand across cosmetics, agriculture, pharmaceuticals and sustainable materials.
13114497
510 views, By CorporateAds
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) NRXP Also Reports Its Superior Preservative-Free IV Ketamine Now Submitted for FDA Abbreviated New Drug Application
223 views, By Navistrat Analytics
The Small Interfering RNAs (siRNAs) Therapeutics market, valued at USD 723.4 million in 2024, is expected to register robust revenue CAGR of 13.4%.
787 views, By OKAVA
OKAVA Pharmaceuticals is a clinical-stage company developing medicines to enable dogs and cats to live longer, healthier lives.

Page: 1 2 NextPage updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share